Coro Plc Debt / Equity
Cos'è Debt / Equity di Coro Plc?
Debt / Equity di Coro Energy Plc è -5.26
Qual è la definizione di Debt / Equity?
Il rapporto debito è un rapporto finanziario che indica la proporzione relativa del patrimonio netto e del debito utilizzato per finanziare le attività di una società.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt / Equity di aziende nel Energy settore su LSE rispetto a Coro Plc
Cosa fa Coro Plc?
Coro Energy plc engages in the exploration, development, and production of oil and natural gas in South East Asia. Its asset portfolio is situated in the west Natuna basin, offshore Indonesia. The company was formerly known as Saffron Energy Plc and changed its name to Coro Energy plc in April 2018. The company was incorporated in 2016 and is based in Leeds, the United Kingdom.
Aziende con debt / equity simili a Coro Plc
- Inspired Entertainment Inc ha Debt / Equity di -5.37
- Real Good Food plc ha Debt / Equity di -5.37
- CareRx ha Debt / Equity di -5.36
- Pixium Vision SA ha Debt / Equity di -5.34
- AutoZone ha Debt / Equity di -5.32
- Jason Industries ha Debt / Equity di -5.26
- Coro Plc ha Debt / Equity di -5.26
- CytomX Therapeutics Inc ha Debt / Equity di -5.25
- Euromax Resources ha Debt / Equity di -5.24
- Sakthi Sugars ha Debt / Equity di -5.23
- Deep Lake Capital Acquisition ha Debt / Equity di -5.22
- Basilea Pharmaceutica AG ha Debt / Equity di -5.22
- Dare Bioscience Inc ha Debt / Equity di -5.22